Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: Results from a survey of healthcare providers in New England

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Krakower, Douglas S ^a,b,c   Oldenburg, Catherine E ^d   Mitty, Jennifer A ^a,b   Wilson, Ira B ^e   Kurth, Ann E ^f   Maloney, Kevin M ^a   Gallagher, Donna ^g   Mayer, Kenneth H ^a,b,c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FENWAY INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BROWN UNIVERSITY   (United States)

^f NEW YORK UNIVERSITY   (United States)

^g New England AIDS Education and Training Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANTIRETROVIRAL TREATMENT; ANTIVIRAL THERAPY; ARTICLE; AWARENESS; CAUCASIAN; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FUNDING; GENDER; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HIV ASSOCIATED DEMENTIA; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INSURANCE; MALE; PRACTICE GUIDELINE; PREEXPOSURE CHEMOPROPHYLAXIS; PREGNANCY; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; PUBLIC HEALTH SERVICE; SIDE EFFECT; TUBERCULOSIS; UNITED STATES; ATTITUDE TO HEALTH; CULTURAL ANTHROPOLOGY; GENERAL PRACTITIONER; HEALTH SURVEY; HIV INFECTIONS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; PSYCHOLOGY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; ATTITUDE OF HEALTH PERSONNEL; CULTURE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW ENGLAND; PHYSICIANS, PRIMARY CARE;

EID: 84940094707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132398     Document Type: Article

References (42)

1. An Q, Prejean J, Hall HI. Racial disparity in U.S. diagnoses of acquired immune deficiency syndrome, 2000-2009. Am J Prev Med 2012, 43:461-466.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
3. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013, 339:966-971.
4. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis 2014, 14:281-290.
5. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009, 360:1815-1826.
6. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. May 1, 2014. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. (Last accessed on December 19, 2014). In. pp. 1-161.
7. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012, 367:399-410.
8. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013, 381:2083-2090.
9. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010, 363:2587-2599.
10. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012, 367:423-434.
11. US Public Health Service. Preexposure Prophylaxis for the Prevention of HIV Infection inthe United States - 2014 Clinical Practice Guideline. Available at http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf (Last accessed December 19, 2014).
12. Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, et al. Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr 2012, 61: e65-69.
13. Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis 2014, 58:704-712.
14. White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS 2012, 26:395-405.
15. Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav 2014, 18:1712-1721.
16. Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis 2013, 13:217.
17. Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS 2013, 27:553-559.
18. Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA. Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J 2012, 105:199-206.
19. Tang EC, Sobieszczyk ME, Shu E, Gonzales P, Sanchez J, Lama JR. Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru. AIDS Res Hum Retroviruses 2014, 30:416-424.
20. Arnold EA, Hazelton P, Lane T, Christopoulos KA, Galindo GR, Steward WT, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One 2012, 7:e40603.
21. New England AIDS Education Training Center Home Page. Available at www.neaetc.org (Last accessed December 19, 2014).
22. Krakower D, Mitty JA, Trinidad J, Mayer KH. HIV Providers' Perceived Barriers and Facilitators to Implementing Treatment as Prevention in Clinical Practice: A Qualitative Study [Abstract 101]. In: Forum for Collaborative HIV Research. Washington, D.C.; 26-28 November 2012.
23. Fowler FJ. Survey research methods. 4th ed. Thousand Oaks: Sage Publications; 2009.
24. Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res 2003, 12:229-238.
25. Iarossi G. The power of survey design: a user's guide for managing surveys, interpreting results, and influencing respondents. Washington, D.C.: World Bank; 2006.
26. Stone VE, Mansourati FF, Poses RM, Mayer KH. Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy. J Gen Intern Med 2001, 16:360-368.
27. Landon BE, Wilson IB, Cohn SE, Fichtenbaum CJ, Wong MD, Wenger NS, et al. Physician specialization and antiretroviral therapy for HIV. J Gen Intern Med 2003, 18:233-241.
28. FDA Approves First Medication to Reduce HIV Risk. U.S. Food and Drug Administration. 16 July 2012. Available at: http://www.fda.gov/forconsumers/consumerupdates/ucm311821.htm (Last accessed December 19, 2014).
29. Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep 2013, 62:463-465.
30. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep 2011, 60:65-68.
31. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep 2012, 61:586-589.
32. Rogers EM. Diffusion of innovations. 5th ed. New York: Free Press; 2003.
33. Berwick DM. Disseminating innovations in health care. JAMA 2003, 289:1969-1975.
34. Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, et al. Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr 2013, 64:79-86.
35. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012, 367:411-422.
36. Olubajo B, Mitchell-Fearon K, Ogunmoroti O. A Comparative Systematic Review of the Optimal CD4 Cell Count Threshold for HIV Treatment Initiation. Interdiscip Perspect Infect Dis 2014, 2014:625670.
37. Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, et al. Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS 2013, 27:1159-1165.
38. Hsu LC, Truong HM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011. J Infect Dis 2014, 209:1310-1314.
39. Tasselli S. Social Networks of Professionals in Health Care Organizations: A Review. Med Care Res Rev 2014, 71:619-660.
40. Averting a Crisis in HIV Care: A Joint Statement of the American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA) on the HIV Medical Workforce. AAHIVM and HIVMA Medical Workforce Working Group. June 2009. Available at http://www.idsociety.org/uploadedFiles/IDSA/Policy-and-Advocacy/Current-Topics-and-Issues/Workforce-and-Training/Statements/AAHIVM%20HIVMA%20Workforce%20Statement%20062509.pdf (Last accessed December 19, 2014).
41. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997, 50:1129-1136.
42. Kellerman SE, Herold J. Physician response to surveys. A review of the literature. Am J Prev Med 2001, 20:61-67.